ATTENTION Neurogene Inc. Investors: You May Have Been Affected by Fraud- Contact Levi & Korsinsky to Discuss Your Rights
Portfolio Pulse from
Levi & Korsinsky has initiated an investigation into Neurogene Inc. (NASDAQ:NGNE) for potential violations of federal securities laws. This follows a press release by Neurogene reporting interim clinical data from a Phase 1/2 trial of NGN-401 gene therapy for Rett syndrome.
November 14, 2024 | 3:45 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Neurogene Inc. is under investigation by Levi & Korsinsky for potential securities law violations following the release of clinical trial data for NGN-401 gene therapy.
The investigation by Levi & Korsinsky into potential securities law violations could negatively impact investor confidence in Neurogene Inc. This follows the release of clinical trial data, which may have prompted the investigation. Legal issues often lead to stock price volatility.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100